Medication adherence and costs of medical care among patients with Parkinson’s disease: an observational study using electronic medical records

0Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Adherence to antiparkinsonian drugs (APDs) is critical for patients with Parkinson’s disease (PD), for which medication is the main therapeutic strategy. Previous studies have focused on specific disorders in a single system when assessing clinical factors affecting adherence to PD treatment, and no international comparative data are available on the medical costs for Chinese patients with PD. The present study aimed to evaluate medication adherence and its associated factors among Chinese patients with PD using a systematic approach and to explore the impact of adequate medication adherence on direct medical costs. Methods: A retrospective analysis was conducted using the electronic medical records of patients with PD from a medical center in China. Patients with a minimum of two APD prescriptions from January 1, 2016 to August 15, 2018 were included. Medication possession ratio (MPR) and proportion of days covered were used to measure APD adherence. Multiple linear regression analysis was used to identify factors affecting APD adherence. Gamma regression analysis was used to explore the impact of APD adherence on direct medical costs. Results: In total, 1,712 patients were included in the study, and the mean MPR was 0.68 (± 0.25). Increased number of APDs and all medications, and higher daily levodopa-equivalent doses resulted in higher MPR (mean difference [MD] = 0.04 [0.03–0.05]; MD = 0.02 [0.01–0.03]; MD = 0.03 [0.01–0.04], respectively); combined digestive system diseases, epilepsy, or older age resulted in lower MPR (MD = -0.06 [-0.09 to -0.03]; MD = -0.07 [-0.14 to -0.01]; MD = -0.02 [-0.03 to -0.01], respectively). Higher APD adherence resulted in higher direct medical costs, including APD and other outpatient costs. For a 0.3 increase in MPR, the two costs increased by $34.42 ($25.43–$43.41) and $14.63 ($4.86–$24.39) per year, respectively. Conclusions: APD adherence rate among Chinese patients with PD was moderate and related primarily to age, comorbidities, and healthcare costs. The factors should be considered when prescribing APDs.

References Powered by Scopus

Adherence to medication

6737Citations
N/AReaders
Get full text

Parkinson's disease

4467Citations
N/AReaders
Get full text

Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3269Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yi, Z., Mao, Y., He, C., Zhang, Y., Zhou, J., & Feng, X. L. (2024). Medication adherence and costs of medical care among patients with Parkinson’s disease: an observational study using electronic medical records. BMC Public Health, 24(1). https://doi.org/10.1186/s12889-024-18431-y

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

63%

Lecturer / Post doc 2

25%

Researcher 1

13%

Readers' Discipline

Tooltip

Nursing and Health Professions 3

43%

Medicine and Dentistry 2

29%

Linguistics 1

14%

Neuroscience 1

14%

Save time finding and organizing research with Mendeley

Sign up for free